BioSpace News Archive

Psilera, a biopharmaceutical company developing next-generation mental health treatments for take home use, announces the selection of their lead clinical candidate, PSIL-006.

A study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone Health, home to the effort’s Clinical Science Core, provides an expanded working definition of long COVID.

Be Biopharma, Inc., a company pioneering the discovery and development of Engineered B Cell Medicines, announced that Chief Executive Officer, Joanne Smith-Farrell, Ph.D., will present at the Jefferies Healthcare Conference being held in New York, NY, June 7-9, 2023.

Illumina announced that based on the preliminary results of its 2023 Annual Meeting, Illumina shareholders have voted to elect eight of nine Illumina director nominees – Francis deSouza, Robert Epstein, MD, Frances Arnold, PhD, Caroline Dorsa, Scott Gottlieb, MD, Gary Guthart, PhD, Philip Schiller, and Sue Siegel, as well as Andrew Teno, to the Board of Directors.

Cingulate Inc. announced it will participate in the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, Los Angeles, California, on June 6th-8th, 2023.

Agile Therapeutics, Inc., a women’s healthcare company, announced the closing of its previously announced public offering of an aggregate of 1,896,286 shares of its common stock, together with accompanying common stock warrants, at a public offering price of $3.9551 per share and accompanying warrants.

23andMe Holding Co., a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, reported its financial results for the fourth quarter and full year of fiscal year 2023, which ended March 31, 2023.

Carmot Therapeutics, Inc., a clinical-stage biotechnology company developing disease-modifying therapies for metabolic diseases, announced a $150 million oversubscribed and up-sized Series E financing.

Jazz Pharmaceuticals plc will host a webcast to review the zanidatamab biliary tract cancers data being featured in an oral presentation at the 2023 American Society of Clinical Oncology Annual Meeting on June 2, 2023.

Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced that management will participate in the Jefferies Healthcare Conference, which is being held in New York, NY, from June 7-9, 2023.